These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35803241)

  • 1. Breaking down a gut-to-brain circuit that prevents malabsorption.
    Jarvie BC; Knight ZA
    Cell; 2022 Jul; 185(14):2393-2395. PubMed ID: 35803241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An inter-organ neural circuit for appetite suppression.
    Zhang T; Perkins MH; Chang H; Han W; de Araujo IE
    Cell; 2022 Jul; 185(14):2478-2494.e28. PubMed ID: 35662413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PYY and GLP-1 contribute to feedback inhibition from the canine ileum and colon.
    Wen J; Phillips SF; Sarr MG; Kost LJ; Holst JJ
    Am J Physiol; 1995 Dec; 269(6 Pt 1):G945-52. PubMed ID: 8572226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of the GI Effects of GLP-1: An Historical Perspective.
    Holst JJ
    Dig Dis Sci; 2022 Jul; 67(7):2716-2720. PubMed ID: 35635627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.
    Dumoulin V; Dakka T; Plaisancie P; Chayvialle JA; Cuber JC
    Endocrinology; 1995 Nov; 136(11):5182-8. PubMed ID: 7588257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The physiological role of GLP-1 in human: incretin, ileal brake or more?
    Schirra J; Göke B
    Regul Pept; 2005 Jun; 128(2):109-15. PubMed ID: 15780430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide YY, glucagon-like peptide-1, and neurotensin responses to luminal factors in the isolated vascularly perfused rat ileum.
    Dumoulin V; Moro F; Barcelo A; Dakka T; Cuber JC
    Endocrinology; 1998 Sep; 139(9):3780-6. PubMed ID: 9724030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipids, CHOs, proteins: can all macronutrients put a 'brake' on eating?
    Shin HS; Ingram JR; McGill AT; Poppitt SD
    Physiol Behav; 2013 Aug; 120():114-23. PubMed ID: 23911804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation.
    le Roux CW; Borg C; Wallis K; Vincent RP; Bueter M; Goodlad R; Ghatei MA; Patel A; Bloom SR; Aylwin SJ
    Ann Surg; 2010 Jul; 252(1):50-6. PubMed ID: 20562614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCK and GLP-1 release in response to proteinogenic amino acids using a small intestine ex vivo model in pigs.
    Müller M; Van Liefferinge E; Navarro M; Garcia-Puig E; Tilbrook A; van Barneveld R; Roura E
    J Anim Sci; 2022 Apr; 100(4):. PubMed ID: 35323927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ileal [correction of ilial] transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery.
    Mason EE
    Obes Surg; 1999 Jun; 9(3):223-8. PubMed ID: 10484306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duodenal and ileal glucose infusions differentially alter gastrointestinal peptides, appetite response, and food intake: a tube feeding study.
    Poppitt SD; Shin HS; McGill AT; Budgett SC; Lo K; Pahl M; Duxfield J; Lane M; Ingram JR
    Am J Clin Nutr; 2017 Sep; 106(3):725-735. PubMed ID: 28701300
    [No Abstract]   [Full Text] [Related]  

  • 13. Is glucagon-like peptide 1 an incretin hormone?
    Nauck MA
    Diabetologia; 1999 Mar; 42(3):373-9. PubMed ID: 10096792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The physiology of glucagon-like peptide 1.
    Holst JJ
    Physiol Rev; 2007 Oct; 87(4):1409-39. PubMed ID: 17928588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats.
    Strader AD; Vahl TP; Jandacek RJ; Woods SC; D'Alessio DA; Seeley RJ
    Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E447-53. PubMed ID: 15454396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections.
    Nauck MA; Siemsglüss J; Orskov C; Holst JJ
    Z Gastroenterol; 1996 Mar; 34(3):159-66. PubMed ID: 8650968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Glucagon-Like Peptide-1 in Energy Homeostasis.
    Salehi M; Purnell JQ
    Metab Syndr Relat Disord; 2019 May; 17(4):183-191. PubMed ID: 30720393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity.
    Flint A; Raben A; Ersbøll AK; Holst JJ; Astrup A
    Int J Obes Relat Metab Disord; 2001 Jun; 25(6):781-92. PubMed ID: 11439290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the gut hormone GLP-1 in the metabolic improvements caused by ileal transposition.
    Gaitonde S; Kohli R; Seeley R
    J Surg Res; 2012 Nov; 178(1):33-9. PubMed ID: 22929182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans.
    Layer P; Holst JJ; Grandt D; Goebell H
    Dig Dis Sci; 1995 May; 40(5):1074-82. PubMed ID: 7729267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.